Exploring the landscape of novel targets & pathways in immuno-oncology

Immuno-Oncology Insights 2023; 4(8), 301–306

DOI: 10.18609/ioi.2023.44

Published: 6 December 2023
Yvonne McGrath

Lauren Coyle, Editor, Immuno-Oncology Insights, speaks to Yvonne McGrath, Chief Scientific Officer, iTeos Therapeutics, about the current and emerging novel targets and pathways for the use of cancer therapy in the I-O field with a focus on small molecules and antibody targets.